WELL Health Technologies Corp. (WELL.TO)
CAD 7.0
(-1.27%)
CAD 7.0
(-1.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 62.58 Million | 76.54 Million | 22.26 Million | -5.38 Million | -2.63 Million | -1.19 Million |
| Net Income | 82 Thousand | 18.67 Million | -30.89 Million | -3.21 Million | -7.79 Million | -2.04 Million |
| Depreciation & Amortization | 60.76 Million | 55.2 Million | 38.21 Million | 4.27 Million | 2.15 Million | 35.93 Thousand |
| Deferred income taxes | -10.42 Million | -978 Thousand | 1.03 Million | -4.86 Million | -1.56 Million | - |
| Stock-based compensation | 26.16 Million | 24.48 Million | 21.01 Million | 4.97 Million | 2.93 Million | 771.06 Thousand |
| Change in working capital | -10.24 Million | -6.05 Million | -11.19 Million | -1.92 Million | 321.66 Thousand | 266.78 Thousand |
| Other non-cash items | -3.75 Million | -14.77 Million | 4.09 Million | -4.62 Million | 1.3 Million | -220.77 Thousand |
| Investing Cash Flow | -106.41 Million | -37.92 Million | -499.77 Million | -44.2 Million | -10.69 Million | -3.49 Million |
| Investments in PPE | -25.38 Million | -6.4 Million | -2.68 Million | -1.13 Million | -472.41 Thousand | -83.7 Thousand |
| Acquisitions | -75.51 Million | -31.12 Million | -421.76 Million | -38.59 Million | -10.3 Million | -3.34 Million |
| Investment purchases | -6.64 Million | -16.51 Million | -3.12 Million | -9.8 Million | - | -264.86 Thousand |
| Sales/Maturities of investments | 11.56 Million | 16.51 Million | 3.12 Million | 9.8 Million | - | - |
| Other Investing Activities | -10.44 Million | -396 Thousand | -75.33 Million | -4.48 Million | 90.37 Thousand | -58.08 Thousand |
| Financing Cash Flow | 39.57 Million | -52.84 Million | 452.53 Million | 120.83 Million | 26.63 Million | 11.21 Million |
| Debt repayment | -52.17 Million | -108.21 Million | -41.19 Million | -2.67 Million | -2.08 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -243 Thousand | - | - | - | - |
| Common Stock Issuance | 810 Thousand | 34.51 Million | 302.5 Million | 117.88 Million | 2.72 Million | 12.06 Million |
| Other Financing Activities | -25.1 Million | 21.09 Million | 191.22 Million | 5.61 Million | 25.98 Million | -851.6 Thousand |
| Accounts receivables | -2.48 Million | -9.37 Million | -13.27 Million | -3.18 Million | -677.56 Thousand | 274.58 Thousand |
| Accounts payables | -9.21 Million | 10.55 Million | 1.59 Million | 1.34 Million | 988.55 Thousand | 278.05 Thousand |
| Inventory | 190 Thousand | -577 Thousand | 876 Thousand | -1.07 Million | -80.37 Thousand | - |
| Other working capital | 1.25 Million | -6.66 Million | -399 Thousand | 991.99 Thousand | 91.04 Thousand | -50.66 Thousand |
| Cash at beginning of period | 48.9 Million | 61.91 Million | 86.89 Million | 15.64 Million | 2.33 Million | 266.47 Thousand |
| Cash at end of period | 43.42 Million | 48.9 Million | 61.91 Million | 86.89 Million | 15.64 Million | 6.8 Million |
| Capital Expenditure | -25.38 Million | -6.4 Million | -2.68 Million | -1.13 Million | -472.41 Thousand | -83.7 Thousand |
| Effect of forex changes on cash | -532 Thousand | 1.21 Million | 9000.00 | - | - | - |
| Net cash flow / Change in cash | -5.48 Million | -13.01 Million | -24.97 Million | 71.24 Million | 13.3 Million | 6.53 Million |
| Free Cash Flow | 37.2 Million | 70.14 Million | 19.58 Million | -6.51 Million | -3.1 Million | -1.27 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 111.71 Million | 19.6 Million | 82 Thousand | 27.81 Million | -4.48 Million | -2.01 Million |
| Depreciation & Amortization | 17.3 Million | 16.56 Million | 60.76 Million | 16.75 Million | 15.44 Million | 14.04 Million |
| Deferred income taxes | -6.77 Million | -1.02 Million | -10.42 Million | -10.42 Million | 503 Thousand | -2.64 Million |
| Stock-based compensation | 4.76 Million | 5.47 Million | 26.16 Million | 6.38 Million | 7.04 Million | 6.13 Million |
| Change in working capital | 14.6 Million | -4.69 Million | -10.24 Million | 6.09 Million | -2.93 Million | -7.17 Million |
| Other non-cash items | -23.14 Million | 6.01 Million | -3.75 Million | -33.85 Million | 4.33 Million | 5.87 Million |
| Investing Cash Flow | -16.57 Million | -5.8 Million | -106.41 Million | -21.22 Million | -61.6 Million | 8 Million |
| Investments in PPE | -4.73 Million | -1.61 Million | -25.38 Million | -19.18 Million | -2.43 Million | -1.76 Million |
| Acquisitions | -10.68 Million | -6.49 Million | -75.51 Million | 6.33 Million | -40.4 Million | -1.66 Million |
| Investment purchases | - | - | -6.64 Million | -5.57 Million | -11.43 Million | -388 Thousand |
| Sales/Maturities of investments | - | 2.39 Million | 11.56 Million | 125 Thousand | 11.43 Million | 388 Thousand |
| Other Investing Activities | -1.15 Million | -95 Thousand | -10.44 Million | -2.92 Million | -18.77 Million | 11.43 Million |
| Financing Cash Flow | -18.53 Million | -9.73 Million | 39.57 Million | 7.79 Million | 47.63 Million | -27.84 Million |
| Debt repayment | -16.03 Million | -4.93 Million | -52.17 Million | -12.23 Million | -17.46 Million | -23.63 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.72 Million | 366 Thousand | 810 Thousand | 165 Thousand | 121 Thousand | 347 Thousand |
| Other Financing Activities | -444 Thousand | -5.16 Million | -25.1 Million | -5.01 Million | 65.09 Million | -4.2 Million |
| Accounts receivables | -51.68 Million | -28.59 Million | -2.48 Million | -9.77 Million | 625 Thousand | 8.26 Million |
| Accounts payables | 6.49 Million | 6.62 Million | -9.21 Million | 665 Thousand | -1.97 Million | -10.41 Million |
| Inventory | -669 Thousand | 6000.00 | 190 Thousand | 164 Thousand | -161 Thousand | 215 Thousand |
| Other working capital | 60.46 Million | 251 Thousand | 1.25 Million | 15.04 Million | -1.42 Million | -5.24 Million |
| Cash at beginning of period | 48.22 Million | 43.42 Million | 48.9 Million | 45.26 Million | 35.63 Million | 41.69 Million |
| Cash at end of period | 46.55 Million | 48.22 Million | 43.42 Million | 43.42 Million | 41.97 Million | 35.63 Million |
| Capital Expenditure | -4.73 Million | -1.61 Million | -25.38 Million | -19.18 Million | -2.43 Million | -1.76 Million |
| Effect of forex changes on cash | 197 Thousand | 581 Thousand | -532 Thousand | -476 Thousand | 403 Thousand | -436 Thousand |
| Net cash flow / Change in cash | -1.67 Million | 4.8 Million | -5.48 Million | -1.84 Million | 6.33 Million | -6.05 Million |
| Free Cash Flow | 28.49 Million | 17.45 Million | 37.2 Million | -6.41 Million | 17.47 Million | 12.44 Million |
MEDCL
HMS
7417
9919
UNF
RTX